Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study has identified two types of these so-called dysbioses in cystic fibrosis. They display distinct ecology and are also likely to respond differently to treatment.
Quelle: ScienceDaily | COPD
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- New insights on polymicrobial infections in chronic lung diseases
- Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with type 2 inflammation
- Discovery into how chronic lung conditions affect children's immune system
- How gum disease aggravates chronic obstructive pulmonary disease
- Healthy omega-3 fats may slow deadly pulmonary fibrosis
- Triple combination therapy brings lasting improvement in cystic fibrosis
- Innovative breathing aid developed
- Spatial lung cell atlas offers insights into disease and immune function
- Household air cleaners improve heart health among individuals with COPD, researchers find
- New study on morphine treatment in people with COPD and severe, long term breathlessness
